Description: Secretogranin II (SCG2) is a neuroendocrine protein belonging to the granin family. Antibodies targeting SCG2 (e.g., ab126935) are used in research applications:
Applications: Immunohistochemistry (IHC-P), Western blot (WB)
Species Reactivity: Human, Mouse, Rat
Target Epitope: Recombinant fragment within Human SCG2 amino acids 1-200
Validation: Confirmed reactivity in U87 xenograft, mouse forebrain, and human colon carcinoma samples
| Parameter | Value/Result |
|---|---|
| Predicted Band Size | 71 kDa |
| Tested Dilutions | 1:250 (IHC), 1:500–1:1000 (WB) |
| Cross-reactivity | None with CCSA-3, CCSA-4, or EPCA-2 |
Description: GUCY2C is an intestinal protein investigated as a therapeutic target in colorectal cancer (CRC):
Therapeutic Role: Biomarker for CRC vaccines, CAR-T therapies, and bispecific antibodies
Clinical Trials: Phase IIa trials ongoing for GUCY2C-targeted vaccines (NCT04111172)
Universal expression in CRC (>95% of cases)
Limited expression in normal tissues (intestinal mucosa only)
Potential companion diagnostic utility for anti-EGFR therapies
| Cohort | Sensitivity | Specificity | AUC |
|---|---|---|---|
| Colorectal Cancer | 95.6% | 97.7% | 0.90 |
| Advanced Adenoma | 100% | 78.4% | 0.90 |
| Nonadvanced Adenoma | 64.4% | 78.4% | - |
CCSA-2 ELISA demonstrated 97.3% sensitivity and 78.4% specificity for detecting advanced colorectal neoplasia at a cutoff of 10.8 µg/mL .
Key studies show IgG2 antibodies induce T-cell infiltration in pancreatic tumors and reduce stromal density in neoadjuvant settings .
CSLM2 belongs to the cellulose synthase-like M (CSLM) family of proteins involved in plant cell wall biosynthesis. Based on current research, CSLM2 appears to play a significant role in the biosynthesis of type II arabinogalactan (AG) linkages. Functional characterization studies in spinach CSLM2 (also known as SOAP5) identified two critical amino acids for glucuronosylation of triterpenoid aglycone. These amino acids are part of the core motifs in the active site of cellulose synthase (CesA), specifically the ED and QxxRW motifs, which in CSLM2 are modified to ES and QxxKW .
Experiments involving site-directed mutagenesis of spinach CSLM2 demonstrated that changing these unique residues to CesA-like residues (S442D or K483R) reduced glucuronosylation activity approximately 10-fold, with activity further reduced 100-fold when both amino acids were changed . This suggests CSLM2's specialized role in polysaccharide synthesis differs from traditional cellulose synthases.
Ectopic expression of CSLM2 in plants leads to several notable changes in cell wall composition and structure. Research shows that CSLM2 expression affects:
Epidermal cell walls - Thickening of outer epidermal walls observed in both CSLM1 and CSLM2a ectopically expressing lines
Pectin composition - Increased epitopes for methyl-esterified (LM20) and de-esterified (LM19) homogalacturonan in epidermal walls
Arabinogalactan distribution - Changes in arabinogalactan (AG) epitopes (LM2), which could be associated with sidechains on rhamnogalacturonan-I or arabinogalactan-proteins
Wall integrity issues - In CSLM2a ectopically expressing lines, time-course experiments revealed aberrant lower epidermal cell wall formation appearing by day 7, with incomplete wall formation and wall stubs
These findings suggest CSLM2's involvement in type II arabinogalactan synthesis and wall integrity maintenance.
Several complementary techniques have proven effective for detecting and visualizing CSLM2 expression and its effects on cell walls:
Quantitative PCR (qPCR) - For measuring relative gene expression levels over time (e.g., maximum expression of CSLM2a was observed on day 4 in time-course experiments)
Immunofluorescence microscopy - Using antibodies like M22 (for rhamnogalacturonan-I), LM2 (arabinogalactan), LM19 and LM20 (homogalacturonan) to visualize epitope distribution in cell walls
Transmission electron microscopy (TEM) with immunogold labeling - Providing higher resolution localization of specific epitopes within cell wall layers
Toluidine blue staining - For detecting aberrant cell wall formation in ectopically expressing plants
Scanning electron microscopy (SEM) - For examining seed surface characteristics in transformed lines
When conducting these analyses, it's recommended to examine multiple independent transgenic lines and perform time-course experiments to track developmental changes in cell wall composition.
Generating specific antibodies for CSLM2 research requires careful consideration of epitope selection and validation. While the search results don't provide specific protocols for CSLM2 antibody generation, general principles for antibody development from the literature can be applied:
Epitope Selection and Antibody Generation:
Select unique regions of CSLM2 protein sequence (particularly Ala50-Gly608 predicted regions, similar to approaches used for other cell wall proteins)
Consider using monoclonal antibody approaches for greater specificity, similar to the approach used for Desmoglein-2 antibody (clone #141409)
Express recombinant protein fragments in appropriate systems for immunization
Validation Strategy:
Western blotting against plant tissue expressing CSLM2 and control/knockout samples
Immunocytochemistry/immunofluorescence on fixed plant tissues with appropriate controls
Use multiple independent antibodies raised against different epitopes if possible
Compare labeling patterns with gene expression data and protein localization predictions
Specificity Testing:
Test against wild-type and knockout/knockdown lines to confirm specificity
Evaluate cross-reactivity with other CSLM family members through comparative immunolabeling
For validation, researchers should follow rigorous controls similar to those demonstrated for the human Desmoglein-2 antibody, which was validated using multiple techniques including Western blot, immunocytochemistry, and Simple Western™ analysis .
Optimizing immunolabeling protocols for CSLM2 detection requires attention to several critical factors:
Sample Preparation:
For light microscopy: Use fresh tissue fixation (4% paraformaldehyde) followed by careful embedding and sectioning
For TEM: Use high-pressure freezing and freeze substitution rather than chemical fixation when possible to better preserve cell wall epitopes
Consider wall permeabilization treatments to improve antibody penetration
Antibody Dilution and Incubation:
Determine optimal antibody concentration through titration experiments (typically starting at 10 μg/mL based on protocols used for other cell wall antibodies)
Optimize incubation time and temperature (typically 3 hours at room temperature or overnight at 4°C)
Use appropriate blocking solutions to minimize non-specific binding
Detection Systems:
Controls to Include:
Negative controls: primary antibody omission, non-expressing tissues, pre-immune serum
Positive controls: tissues known to express CSLM2
Comparative controls: multiple tissue types and developmental stages
The immunofluorescence approach used for cell wall epitope detection in CSLM2 ectopic expression studies provides a good methodological foundation, with attention to epitope preservation and appropriate controls .
Reliable quantification of CSLM2 expression and its effects requires multiple complementary approaches:
Gene Expression Quantification:
RT-qPCR with appropriate reference genes for normalization
RNA-seq for genome-wide expression analysis
Consider time-course experiments to capture dynamic expression patterns
Protein Level Quantification:
Cell Wall Composition Analysis:
Monosaccharide composition analysis
Linkage analysis to detect specific changes in polysaccharide structure
Quantification of immunolabeling intensity across multiple samples and microscopy fields
Phenotypic Measurements:
Morphometric analysis of cell dimensions and wall thickness
Quantification of wall abnormalities (e.g., percentage of cells with wall stubs)
Statistical analysis comparing multiple independent transgenic lines
For the most robust analysis, researchers should combine multiple quantification approaches. For example, in CSLM2 studies, researchers employed both qPCR for gene expression quantification and measured wall thickness changes through TEM, correlating gene expression levels with phenotypic outcomes over a time course .
Biophysics-informed models represent a cutting-edge approach to designing antibodies with greater specificity for research applications, including potential applications for CSLM2 research:
Mode-Based Modeling Approach:
Applications for CSLM2 Research:
Design antibodies that can distinguish between highly similar CSLM family members
Create antibodies specific to different functional domains or conformational states of CSLM2
Generate antibodies with customized cross-reactivity profiles for comparative studies
Implementation Strategy:
Research demonstrates that this approach can successfully predict antibody variants not present in initial libraries that maintain specificity for target ligands. The model's capacity to propose novel antibody sequences with customized specificity profiles would be particularly valuable for distinguishing between closely related CSLM family members .
Studying CSLM2 interactions with other cell wall components requires sophisticated approaches that go beyond basic localization:
Co-localization and Proximity Studies:
Dual immunolabeling with antibodies against CSLM2 and potential interacting partners
Super-resolution microscopy to improve spatial resolution below diffraction limit
Proximity ligation assays to detect protein-protein interactions in situ
Biochemical Interaction Analysis:
Co-immunoprecipitation of CSLM2 with interacting proteins
Pull-down assays using recombinant CSLM2 domains
Crosslinking approaches to capture transient interactions
Genetic Approaches:
Gene co-expression analysis to identify potential functional partners
Genetic interaction studies using double mutants or RNAi approaches
CRISPR-based genome editing to modify specific interaction domains
Structural Analysis:
Cryo-electron microscopy of CSLM2-containing complexes
X-ray crystallography of CSLM2 domains with binding partners
Molecular modeling based on homologous structures
Evidence from immunogold TEM studies of CSLM ectopically expressing plants shows changes in epitope distribution patterns that suggest altered interactions with cell wall components. For example, the RG-I epitope (detected by M22) was found predominantly adjacent to the inner wall or in internal membranes in CSLM-expressing lines, whereas in controls the epitope was only detected in the wall .
CSLM2 antibodies offer powerful tools for investigating stress responses and cell wall remodeling:
Stress-Induced Changes in CSLM2 Expression:
Immunoblotting and immunolabeling to track CSLM2 protein levels and localization during stress
Comparison across multiple stress conditions (drought, salinity, pathogens)
Correlation with transcriptomic data on stress-responsive gene expression
Cell Wall Remodeling Visualization:
Time-course immunolabeling during stress response
3D reconstruction of immunolabeled tissues to track spatial patterns of wall remodeling
Quantitative analysis of epitope distribution changes
Functional Studies:
Antibody inhibition experiments to block CSLM2 function during stress response
Combination with metabolic labeling to track newly synthesized wall components
Correlative light and electron microscopy for connecting molecular changes to ultrastructural remodeling
Comparative Studies:
Cross-species immunolabeling to identify conserved stress response mechanisms
Analysis across different tissue types to identify tissue-specific responses
Developmental stage comparisons to identify age-dependent responses
The observed thickening of outer epidermal walls and altered distribution of cell wall epitopes in CSLM2 ectopically expressing plants suggests a role in wall remodeling that could be relevant to stress responses . Researchers could leverage these observations to investigate natural wall remodeling during environmental challenges.
Contradictory immunolabeling results are common challenges in antibody-based research. Here's a methodical approach to resolving such contradictions:
Antibody Validation Reassessment:
Confirm antibody specificity using knockout/knockdown controls
Test multiple antibodies targeting different epitopes of CSLM2
Validate antibody lots for consistency (lot-to-lot variation can occur)
Technical Considerations:
Examine fixation and sample preparation effects on epitope accessibility
Compare different detection systems (fluorescence vs. enzymatic)
Evaluate blocking conditions and non-specific binding
Standardize image acquisition parameters across experiments
Biological Interpretation:
Consider developmental stage differences in CSLM2 expression/localization
Evaluate tissue-specific differences in cell wall composition affecting epitope accessibility
Assess possible post-translational modifications affecting antibody recognition
Examine potential conformational changes in CSLM2 under different conditions
Complementary Approaches:
Supplement immunolabeling with gene expression analysis
Add fluorescent protein tagging approaches (if genetically tractable)
Employ biochemical fractionation to confirm localization
In CSLM research, time-course experiments revealed that aberrant cell wall phenotypes appeared at different times for CSLM1 (day 5) versus CSLM2a (day 7) expressing plants . This temporal difference highlights the importance of considering timing when interpreting seemingly contradictory results.
Robust statistical analysis of immunolabeling data requires consideration of several factors:
Quantification Approaches:
Intensity measurements: Mean fluorescence intensity, integrated density
Distribution analysis: Coefficient of variation, clustering algorithms
Colocalization metrics: Pearson's correlation, Manders' coefficients
Morphological measurements: Wall thickness, cell dimensions
Experimental Design Considerations:
Recommended Statistical Tests:
For normally distributed data: ANOVA with post-hoc tests, t-tests
For non-normally distributed data: Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)
For complex datasets: Linear mixed models accounting for nested variables
For spatial data: Spatial statistics approaches (Ripley's K function, etc.)
Visualization Approaches:
Box plots showing distribution of measurements
Violin plots for better visualization of data distribution
Heatmaps for multivariate analysis
Scatter plots for correlation analysis
In the CSLM studies, researchers tested multiple independent transgenic lines (typically 3-4) to account for potential position effects and genetic background variation . This approach strengthens statistical robustness and should be considered standard practice.
Distinguishing direct from indirect effects requires careful experimental design and mechanistic analysis:
Temporal Analysis:
Track gene expression, protein accumulation, and phenotypic changes over time
Establish sequence of events through time-course experiments
Identify earliest detectable changes as potential direct effects
Domain-Specific Approaches:
Substrate Analysis:
Identify direct substrates through in vitro enzymatic assays
Track metabolic fate of potential substrates in vivo
Conduct metabolic labeling studies to follow product formation
Combined Approaches:
Correlate biochemical activity with observed phenotypes
Use genetic complementation to rescue specific aspects of mutant phenotypes
Employ systems biology approaches to model potential direct vs. cascade effects
The research on spinach CSLM2 provides a good example of distinguishing direct effects - its role in glucuronosylation of triterpenoid aglycone was directly demonstrated through biochemical assays, while effects on cell wall structure required more complex interpretation .
Several emerging technologies show promise for advancing CSLM2 antibody research:
Advanced Imaging Technologies:
Super-resolution microscopy (STORM, PALM, SIM) for nanoscale visualization of CSLM2 localization
Expansion microscopy for physical magnification of samples
Correlative light and electron microscopy (CLEM) for connecting molecular and ultrastructural data
Live-cell imaging with novel cell wall probes for dynamic studies
Antibody Engineering Approaches:
Nanobodies (single-domain antibodies) for improved penetration into dense cell wall structures
Bispecific antibodies for simultaneous detection of CSLM2 and interacting partners
Computationally designed antibodies with enhanced specificity and affinity
Split-antibody complementation for detecting protein-protein interactions
Multi-omics Integration:
Spatial transcriptomics combined with immunolabeling
Glycomics approaches to connect CSLM2 activity with cell wall polysaccharide profiles
Proteomics of immunoprecipitated complexes
Integration with metabolomics data for pathway analysis
High-throughput Approaches:
Automated imaging and image analysis for large-scale phenotyping
Machine learning for pattern recognition in complex immunolabeling datasets
CRISPR screens combined with antibody-based detection
Biophysics-informed models for antibody design represent a particularly promising advance, as they enable the design of antibodies with customized specificity profiles that could distinguish between highly similar CSLM family members or different functional states .
CSLM2 research offers several avenues for exploring plant evolution and adaptation:
Evolutionary Analysis:
Comparative genomics of CSLM genes across plant lineages
Analysis of selection pressure on specific domains
Reconstruction of ancestral CSLM sequences and functional testing
Investigation of CSLM gene family expansion/contraction events
Adaptive Significance:
Analysis of CSLM2 expression and function across ecological gradients
Investigation of natural variation in CSLM2 sequence and expression
Connection between CSLM-dependent cell wall properties and adaptation to specific environments
Analysis of CSLM2 involvement in stress responses
Research Approaches:
Cross-species antibody studies to track conservation of protein localization and function
Heterologous expression studies to test functional conservation
Immunolabeling of diverse plant species to correlate wall composition with ecological niche
Genetic manipulation in model and non-model species
Potential Significance:
Understanding the evolution of complex cell walls in land plants
Identifying key innovations in cell wall biosynthesis during plant diversification
Connecting cell wall diversity to adaptive strategies
The divergence in key amino acids within the active site of CSLM2 compared to canonical CesA proteins (ES instead of ED, and QxxKW instead of QxxRW) suggests evolutionary adaptation for specialized functions, potentially related to the synthesis of specific cell wall components like type II arabinogalactans .
Interdisciplinary approaches offer significant potential for advancing CSLM2 antibody research:
Computational-Experimental Integration:
Bioengineering Approaches:
Microfluidic systems for high-throughput antibody screening
Novel immobilization strategies for difficult-to-access cell wall epitopes
Advanced biomaterials incorporating antibodies for controlled release studies
Synthetic biology approaches to engineer novel detection systems
Cross-disciplinary Applications:
Agricultural biotechnology: Engineering cell walls for enhanced stress resistance
Bioenergy research: Modifying cell walls for improved degradability
Materials science: Developing plant-inspired biomaterials
Medical research: Translating plant glycobiology insights to human systems
Collaborative Framework:
Partnerships between structural biologists, immunologists, and plant scientists
Integration of glycobiology and protein engineering expertise
Collaboration between academic and industrial researchers
The successful development of biophysics-informed models for antibody design demonstrates the value of interdisciplinary approaches combining experimental selection techniques with computational modeling . Similar approaches could be applied specifically to CSLM2 antibody development.